Tan Y, Xin L, Wang Q, Xu R, et al. FLT3-Selective PROTAC: Enhanced Safety and Increased Synergy with Venetoclax in FLT3-ITD Mutated Acute Myeloid Leukemia. Cancer Lett 2024 May 3:216933. doi: 10.1016/j.canlet.2024.216933.
PMID: 38705564